NetSlim: High-confidence curated signaling maps

Database

Volumn 2011, Issue , 2011, Pages

  Raju, Rajesh ^a,b   Nanjappa, Vishalakshi ^a   Balakrishnan, Lavanya ^a,b   Radhakrishnan, Aneesha ^a,c   Thomas, Joji Kurian ^a   Sharma, Jyoti ^d   Tian, Maozhen ^e   Palapetta, Shyam Mohan ^a,c   Subbannayya, Tejaswini ^a   Sekhar, Nirujogi Raja ^a,c   Muthusamy, Babylakshmi ^a,c   Goel, Renu ^a,b   Subbannayya, Yashwanth ^a,f   Telikicherla, Deepthi ^a,b   Bhattacharjee, Mitali ^a,g   Pinto, Sneha M ^a,d   Syed, Nazia ^a   Srikanth, Manda Srinivas ^a   Sathe, Gajanan J ^a   Ahmad, Sartaj ^a   Chavan, Sandip N ^a   Kumar, Ghantasala S Sameer ^a,b   Marimuthu, Arivusudar ^a,d   Prasad, T S K ^a,c   Harsha, H C ^a   Rahiman, B Abdul ^b   Ohara, Osamu ^h   Bader, Gary D ⁱ   Mohan, S Sujatha ^a,b,h   Schiemann, William P ^e   Pandey, Akhilesh ^j   more..

^a INSTITUTE OF BIOINFORMATICS   (India)

^b KUVEMPU UNIVERSITY   (India)

^c PONDICHERRY UNIVERSITY   (India)

^d MANIPAL UNIVERSITY   (India)

^e CASE WESTERN RESERVE UNIVERSITY   (United States)

^f RAJIV GANDHI UNIVERSITY OF HEALTH SCIENCES   (India)

^g AMRITA UNIVERSITY   (India)

^h Institute of Physical and Chemical Research   (Japan)

ⁱ UNIVERSITY OF TORONTO   (Canada)

^j JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; COMPUTER INTERFACE; DATA BASE; FACTUAL DATABASE; INTERNET; METABOLISM; SIGNAL TRANSDUCTION;

DATABASE MANAGEMENT SYSTEMS; DATABASES, FACTUAL; INTERNET; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA; USER-COMPUTER INTERFACE;

EID: 84864041694     PISSN: 17580463     EISSN: None     Source Type: Journal    
DOI: 10.1093/database/bar032     Document Type: Article

References (58)

1. Saraiya, P., North, C. and Duca, K. (2005b) Visualizing biological pathways: requirements analysis, systems evaluation and research agenda. Inform. Visual., 4, 1-15.
2. Ihekwaba, A. E., Nguyen, P. T. and Priami, C. (2009) Elucidation of functional consequences of signalling pathway interactions. BMC Bioinformatics, 6, 370.
3. Fraser, I. D. and Germain, R. N. (2009) Navigating the network: signaling cross-talk in hematopoietic cells. Nat. Immunol., 10, 327-331.
4. Albert, R. and Wang, R. S. (2009) Discrete dynamic modeling of cellular signaling networks. Methods Enzymol., 467, 281-306.
5. Kandasamy, K., Mohan, S. S., Raju, R. et al. (2010) NetPath: a public resource of curated signal transduction pathways. Genome Biol., 11, R3.
6. Kandasamy, K., Keerthikumar, S., Raju, R. et al. (2009) PathBuilder-open source software for annotating and developing pathway resources. Bioinformatics, 25, 2860-2862.
7. Bader., G. D., Cary, M. P. and Sander, C. (2006) Pathguide: a pathway resource list. Nucleic Acids Res., 34, D504-D506.
8. Saraiya, P., North, C. and Duca, K. (2005a) An insight-based methodology for evaluating bioinformatics visualizations. IEEE Trans. Visualis Comput. Graphics., 11, 443-456. (Pubitemid 41049906)
9. The Cancer Cell Map (http://cancer.cellmap.org/) (20 November 2010, date last accessed).
10. Pathway Commons (http://www.pathwaycommons.org/) (20 November 2010, date last accessed).
11. Hermjakob, H., Montecchi-Palazzi, L., Bader, G. et al. (2004) The HUPO PSI's molecular interaction format-A community standard for the representation of protein interaction data. Nat. Biotechnol., 22, 177-183. (Pubitemid 38160532)
12. Demir, E., Cary, M. P., Paley, S. et al. (2010) The BioPAX community standard for pathway data sharing. Nat. Biotechnol., 28, 935-942.
13. PathVisio (www.PathVisio.org) (20 November 2010, date last accessed).
14. Salomonis, N., Hanspers, K., Zambon, A. C. et al. (2007) GenMAPP 2: new features and resources for pathway analysis. BMC Bioinformatics, 24, 217.
15. Blobe, G. C., Schiemann, W. P. and Lodish, H. F. (2000) Role of transforming growth factor beta in human disease. N. Engl. J. Med., 342, 1350-1358. (Pubitemid 30408720)
16. Galliher, A. J., Neil, J. R. and Schiemann, W. P. (2006) Role of transforming growth factor-beta in cancer progression. Future Oncol., 2, 743-763. (Pubitemid 44941992)
17. Schiemann, W. P. (2007) Targeted TGF-beta chemotherapies: friend or foe in treating human malignancies? Expert Rev. Anticancer Ther., 7, 609-611. (Pubitemid 46805559)
18. Tian, M. and Schiemann, W. P. (2009) The TGF-beta paradox in human cancer: an update. Future Oncol., 5, 259-271.
19. Schiemann, B. J., Neil J., R. and Schiemann, W. P. (2003) SPARC inhibits epithelial cell proliferation in part through stimulation of the transforming growth factor-beta-signaling system. Mol. Biol. Cell., 14, 3977-3988. (Pubitemid 37186302)
20. Annes, J. P., Munger, J. S. and Rifkin, D. B. (2003) Making sense of latent TGFbeta activation. J. Cell Sci., 116, 217-224. (Pubitemid 36163863)
21. Bornstein, P. (2009) Thrombospondins function as regulators of angiogenesis. J. Cell Commun. Signal, 3, 189-200.
22. Sheppard, D. (2005) Integrin-mediated activation of latent transforming growth factor beta. Cancer Metastasis Rev., 24, 395-402. (Pubitemid 41569979)
23. Wrana, J. L., Attisano, L., Cárcamo, J. et al. (1992) TGF beta signals through a heteromeric protein kinase receptor complex. Cell, 71, 1003-1014.
24. Wieser, R., Attisano, L., Wrana, J. L. and Massagué , J. (1993) Signaling activity of transforming growth factor beta type II receptors lacking specific domains in the cytoplasmic region. Mol. Cell Biol., 13, 7239-7247. (Pubitemid 23354247)
25. Lin, H. Y. and Moustakas, A. (1994) TGF-beta receptors: structure and function. Cell Mol. Biol., 40, 337-349.
26. Blobe, G. C., Schiemann, W. P., Pepin, M. C. et al. (2001) Functional roles for the cytoplasmic domain of the type III transforming growth factor beta receptor in regulating transforming growth factor beta signaling. J. Biol. Chem., 276, 24627-24637.
27. Wrana, J. L., Attisano, L., Wieser, R. et al. (1994) Mechanism of activation of the TGF-beta receptor. Nature, 370, 341-347. (Pubitemid 2110860)
28. Chen, F. and Weinberg, R. A. (1995) Biochemical evidence for the autophosphorylation and transphosphorylation of transforming growth factor beta receptor kinases. Proc. Natl Acad. Sci. USA, 92, 1565-1569.
29. Abdollah, S., Macías-Silva, M., Tsukazaki, T. et al. (1997) TbetaRI phosphorylation of Smad2 on Ser465 and Ser467 is required for Smad2-Smad4 complex formation and signaling. J. Biol. Chem., 272, 27678-27685. (Pubitemid 27473563)
30. Nakao, A., Imamura, T., Souchelnytskyi, S. et al. (1997) TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4. EMBO J., 16, 5353-5362. (Pubitemid 27380143)
31. Tsukazaki, T., Chiang, T. A., Davison, A. F. et al. (1998) SARA, a FYVE domain protein that recruits Smad2 to the TGFbeta receptor. Cell, 95, 779-791. (Pubitemid 29014458)
32. Miura, S., Takeshita, T., Asao, H. et al. (2000) Hgs (Hrs), a FYVE domain protein, is involved in Smad signaling through cooperation with SAR A. Mol. Cell Biol., 20, 9346-9355. (Pubitemid 32246119)
33. Lin, H. K., Bergmann, S. and Pandolfi, P. P. (2004) Cytoplasmic PML function in TGF-beta signalling. Nature, 431, 205-211. (Pubitemid 39243475)
34. Hocevar, B. A., Smine, A., Xu, X. X. and Howe, P. H. (2001) The adaptor molecule Disabled-2 links the transforming growth factor beta receptors to the Smad pathway. EMBO J., 20, 2789-2801. (Pubitemid 32938562)
35. Hayashi, H., Abdollah, S., Qiu, Y. et al. (1997) The MAD-related protein Smad7 associates with the TGFbeta receptor and functions as an antagonist of TGFbeta signaling. Cell, 89, 1165-1173. (Pubitemid 127678749)
36. Nakao, A., Afrakhte, M., Moré n, A. et al. (1997) Identification of Smad7, a TGFbeta-inducible antagonist of TGF-beta signalling. Nature, 389, 631-635. (Pubitemid 27446184)
37. Datta, P. K. and Moses, H. L. (2000) STRAP and Smad7 synergize in the inhibition of transforming growth factor beta signaling. Mol. Cell. Biol., 20, 3157-3167. (Pubitemid 30215028)
38. Ibarrola, N., Kratchmarova, I., Nakajima, D. et al. (2004) Cloning of a novel signaling molecule, AMSH-2, that potentiates transforming growth factor beta signaling. BMC Cell. Biol., 5, 2.
39. Koinuma, D., Shinozaki, M., Komuro, A. et al. (2003) Arkadia amplifies TGF-beta superfamily signalling through degradation of Smad7. EMBO J., 22, 6458-6470. (Pubitemid 38009594)
40. Massagué , J., Seoane, J. and Wotton, D. (2005) Smad transcription factors. Genes Dev., 19, 2783-2810. (Pubitemid 41739965)
41. Yi, J. Y., Shin, I. and Arteaga, C. L. (2005) Type I transforming growth factor beta receptor binds to and activates phosphatidylinositol 3-kinase. J. Biol. Chem., 280, 10870-10876. (Pubitemid 40395952)
42. Kato, M., Putta, S., Wang, M. et al. (2009) TGF-beta activates Akt kinase through a microRNA-dependent amplifying circuit targeting PTE N. Nat. Cell. Biol., 11, 881-889.
43. Lamouille, S. and Derynck, R. (2007) Cell size and invasion in TGF-beta-induced epithelial to mesenchymal transition is regulated by activation of the mTOR pathway. J. Cell Biol., 178, 437-451. (Pubitemid 47196152)
44. Galliher, A. J. and Schiemann, W. P. (2006) Beta3 integrin and Src facilitate transforming growth factor-beta mediated induction of epithelial-mesenchymal transition in mammary epithelial cells. Breast Cancer Res., 8, R42.
45. Wendt, M. K. and Schiemann, W. P. (2009) Therapeutic targeting of the focal adhesion complex prevents oncogenic TGF-beta signaling and metastasis. Breast Cancer Res., 11, R68.
46. Lee, M. K., Pardoux, C., Hall, M. C. et al. (2007) TGF-beta activates Erk MAP kinase signalling through direct phosphorylation of Shc A. EMBO J., 26, 3957-3967. (Pubitemid 47367487)
47. Meriane, M., Charrasse, S., Comunale, F. et al. (2002) Transforming growth factor beta activates Rac1 and Cdc42Hs GTPases and the JNK pathway in skeletal muscle cells. Biol Cell., 94, 535-543. (Pubitemid 36113703)
48. Park, J. I., Lee, M. G., Cho, K. et al. (2003) Transforming growth factor-beta1 activates interleukin-6 expression in prostate cancer cells through the synergistic collaboration of the Smad2, p38-NF-kappaB, JNK, and Ras signaling pathways. Oncogene., 22, 4314-4332. (Pubitemid 36897963)
49. Kanehisa, M., Goto, S., Kawashima, S. et al. (2004) The KEGG resource for deciphering the genome. Nucleic Acids Res., 32, D277-D280. (Pubitemid 38081656)
50. Schaefer, C. F., Anthony, K., Krupa, S. et al. (2009) PID: the Pathway Interaction Database. Nucleic Acids Res., 37, D674-D679.
51. Gough, N. R. (2002) Science's signal transduction knowledge environment: the connections maps database. Ann. NY Acad. Sci., 971, 585-587. (Pubitemid 35305362)
52. Matthews, L., Gopinath, G., Gillespie, M. et al. (2009) Reactome knowledgebase of human biological pathways and processes. Nucleic Acids Res., 37, D619-D622.
53. Mi, H., Guo, N., Kejariwal, A. and Thomas, P. D. (2007) PANTHER version 6: protein sequence and function evolution data with expanded representation of biological pathways. Nucleic Acids Res., 35, D247-D252. (Pubitemid 46056208)
54. Shannon, P., Markiel, A., Ozier, O. et al. (2003) Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res., 13, 2498-2504. (Pubitemid 37428274)
55. Dilek, A., Belviranli, M. E. and Dogrusoz, U. (2010) VISIBIOweb: visualization and layout services for BioPAX pathway models. Nucleic Acids Res., 38, W150-W154.
56. Babur, O., Dogrusoz, U., Demir, E. and Sander, C. (2010) ChiBE: interactive visualization and manipulation of BioPAX pathway models. Bioinformatics, 26, 429-431.
57. Creative Commons license version 2.5 (http://creativecommons.org/ licenses/by/2.5/) (20 November 2010, date last accessed).
58. Le Novère, N., Hucka, M., Mi, H. et al. (2009) The systems biology graphical notation. Nat Biotechnol., 27, 735-741.